Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020
October 26, 2020 at 08:36 am
Share
Teyi Pharmaceutical Group Co.,Ltd announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 433.080 million compared to CNY 686.426 million a year ago. Operating income was CNY 46.434 million compared to CNY 158.854 million a year ago. Net income was CNY 28.771 million compared to CNY 134.227 million a year ago. Basic earnings per share from continuing operations was CNY 0.14 compared to CNY 0.67 a year ago. Diluted earnings per share from continuing operations was CNY 0.14 compared to CNY 0.65 a year ago.
TEYI PHARMACEUTICAL GROUP CO., LTD, formerly Guangdong Taicheng Pharmaceutical Co., Ltd., is principally engaged in the production and sale of pharmaceuticals. The Company primarily provides Chinese traditional patent medicines, including cough arresting and phlegm removing medicine series, kidney reinforcing medicine series and anti-infection medicine series, among others. The Company's products mainly include tablets, granules, medicinal tea, syrup, decocted extracts, capsules, powder, ointment, cream, as well as oral solutions, among others.
TEYI PHARMACEUTICAL GROUP CO.,LTD 
